Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/did-hyperglycemia-affect-inavolisib-efficacy-patients-breast-2026a1000fgf?src=rss
Author :
Publish date : 2026-05-13 13:13:00
Copyright for syndicated content belongs to the linked Source.
